Clinical trial

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

NCT00645190

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-03-01

PhasePHASE3

Study timeline

Study start (unknown)2004-03-01Date precision: month

Registry last updated2011-05-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

Galantamine HBrDRUG

Sponsors & collaborators

Xian-Janssen Pharmaceutical Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00645190 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.